These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 19048778)
1. [Significant role of poloxamer in drug transport across blood-brain barrier]. Zhang W; Fang XL Yao Xue Xue Bao; 2008 Sep; 43(9):890-7. PubMed ID: 19048778 [TBL] [Abstract][Full Text] [Related]
2. Effects of aripiprazole and its active metabolite dehydroaripiprazole on the activities of drug efflux transporters expressed both in the intestine and at the blood-brain barrier. Nagasaka Y; Oda K; Iwatsubo T; Kawamura A; Usui T Biopharm Drug Dispos; 2012 Sep; 33(6):304-15. PubMed ID: 22847220 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of drug efflux transporter liabilities of darifenacin in cell culture models of the blood-brain and blood-ocular barriers. Miller DW; Hinton M; Chen F Neurourol Urodyn; 2011 Nov; 30(8):1633-8. PubMed ID: 21826715 [TBL] [Abstract][Full Text] [Related]
4. Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. Kabanov AV; Batrakova EV; Miller DW Adv Drug Deliv Rev; 2003 Jan; 55(1):151-64. PubMed ID: 12535579 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats. Hoffmann K; Löscher W Epilepsia; 2007 Apr; 48(4):631-45. PubMed ID: 17437408 [TBL] [Abstract][Full Text] [Related]
6. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation. Roberts LM; Black DS; Raman C; Woodford K; Zhou M; Haggerty JE; Yan AT; Cwirla SE; Grindstaff KK Neuroscience; 2008 Aug; 155(2):423-38. PubMed ID: 18619525 [TBL] [Abstract][Full Text] [Related]
7. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD). Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906 [TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein restricts the penetration of oseltamivir across the blood-brain barrier. Ose A; Kusuhara H; Yamatsugu K; Kanai M; Shibasaki M; Fujita T; Yamamoto A; Sugiyama Y Drug Metab Dispos; 2008 Feb; 36(2):427-34. PubMed ID: 18039806 [TBL] [Abstract][Full Text] [Related]
9. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium. Swed A; Eyal S; Madar I; Zohar-Kontante H; Weiss L; Hoffman A Mol Pharm; 2009; 6(6):1883-90. PubMed ID: 19722701 [TBL] [Abstract][Full Text] [Related]
10. Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly. Miller DS Adv Cancer Res; 2015; 125():43-70. PubMed ID: 25640266 [TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate. Kodaira H; Kusuhara H; Fujita T; Ushiki J; Fuse E; Sugiyama Y J Pharmacol Exp Ther; 2011 Dec; 339(3):935-44. PubMed ID: 21934030 [TBL] [Abstract][Full Text] [Related]
12. Altered glycaemia differentially modulates efflux transporter expression and activity in hCMEC/D3 cell line. Sajja RK; Cucullo L Neurosci Lett; 2015 Jun; 598():59-65. PubMed ID: 25982326 [TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice. Uchida Y; Ohtsuki S; Kamiie J; Terasaki T J Pharmacol Exp Ther; 2011 Nov; 339(2):579-88. PubMed ID: 21828264 [TBL] [Abstract][Full Text] [Related]
14. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier. Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220 [TBL] [Abstract][Full Text] [Related]
15. Brain penetration of ivermectin and selamectin in mdr1a,b P-glycoprotein- and bcrp- deficient knockout mice. Geyer J; Gavrilova O; Petzinger E J Vet Pharmacol Ther; 2009 Feb; 32(1):87-96. PubMed ID: 19161460 [TBL] [Abstract][Full Text] [Related]
16. Role of breast cancer resistance protein (BCRP) as active efflux transporter on blood-brain barrier (BBB) permeability. Garg P; Dhakne R; Belekar V Mol Divers; 2015 Feb; 19(1):163-72. PubMed ID: 25502234 [TBL] [Abstract][Full Text] [Related]
17. Abcc4 together with abcb1 and abcg2 form a robust cooperative drug efflux system that restricts the brain entry of camptothecin analogues. Lin F; Marchetti S; Pluim D; Iusuf D; Mazzanti R; Schellens JH; Beijnen JH; van Tellingen O Clin Cancer Res; 2013 Apr; 19(8):2084-95. PubMed ID: 23461902 [TBL] [Abstract][Full Text] [Related]
18. Zinc finger nuclease-mediated gene knockout results in loss of transport activity for P-glycoprotein, BCRP, and MRP2 in Caco-2 cells. Sampson KE; Brinker A; Pratt J; Venkatraman N; Xiao Y; Blasberg J; Steiner T; Bourner M; Thompson DC Drug Metab Dispos; 2015 Feb; 43(2):199-207. PubMed ID: 25388687 [TBL] [Abstract][Full Text] [Related]
19. Constitutive androstane receptor upregulates Abcb1 and Abcg2 at the blood-brain barrier after CITCO activation. Lemmen J; Tozakidis IE; Bele P; Galla HJ Brain Res; 2013 Mar; 1501():68-80. PubMed ID: 23340159 [TBL] [Abstract][Full Text] [Related]
20. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy. Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A Brain Res; 2009 Aug; 1283():186-93. PubMed ID: 19505448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]